Javascript must be enabled to continue!
ENDOSCOPIC TREATMENT FOR EARLY COLORECTAL CANCER
View through CrossRef
Relevance: In recent years, significant breakthroughs have occurred in the endoscopic treatment of cancerous and precancerous lesions
of the gastrointestinal tract. Endoscopic mucosal resection (EMR) is a simple and effective method of treating most benign gastrointestinal
tract lesions. However, with the introduction of endoscopic submucosal dissection (ESD) and full-thickness endoscopic resection (EFTR), the
ЛЕЧЕНИЕ
38 Онкология и Радиология Казахстана, №4 (70) 2023
volume of lesions subject to endoscopic treatment has significantly expanded even in the colon. Currently, these methods are regularly used
not only for the treatment of benign tumors but also for complex resection of early stages of colorectal cancer. For the first time in Kazakhstan,
the presented article analyzed the cases of endoscopic removal of epithelial formations of the large intestine performed at an oncological clinic
from 2020 to 2023.
The aim was to evaluate the use of endoscopic treatment of early colorectal cancer.
Methods: The article presents a retrospective analysis of 68 cases of endoscopic removal of epithelial formations of the colon performed from
2020 to 2023 at the Center of Expert Endoscopy and Interventional Radiology of the National Scientific Cancer Center (Astana, Kazakhstan).
Results: In 2020-2023, 68 endoscopic extractions of colon tumors were performed, including 25 outpatient and 43 inpatient manipulations.
Out of 43 inpatient cases, endoscopic dissection in the submucosal layer was performed in 9 cases, and endoscopic mucosal resection of tumors
of the large intestine was performed in 34 cases. Morphologically, we found hyperplastic polyps in 11 cases, lipomas in 2 cases, tubulovillous
adenomas with mild dysplasia – 43 cases, tubulovillous adenomas with severe dysplasia – 11 cases, carcinoma in situ – 3 cases, and adenocarcinoma with invasion – 3 cases.
Conclusion: When detecting benign neoplasms with dysplasia and early colorectal cancer, minimally invasive technologies (EMR, ESD,
EFTR) should be the first preferred treatment method and only if they cannot be performed and there is a high risk of invasion into the underlying layers, and therefore, if endoscopic treatment is not radical, clinicians should choose surgical radical treatment. Patients should
be informed about the availability of the latest methods of local treatment in the Republic through the financing of the Compulsory Medical
Insurance Fund (CMIF)
Kazakh Institute of Oncology and Radiology
Title: ENDOSCOPIC TREATMENT FOR EARLY COLORECTAL CANCER
Description:
Relevance: In recent years, significant breakthroughs have occurred in the endoscopic treatment of cancerous and precancerous lesions
of the gastrointestinal tract.
Endoscopic mucosal resection (EMR) is a simple and effective method of treating most benign gastrointestinal
tract lesions.
However, with the introduction of endoscopic submucosal dissection (ESD) and full-thickness endoscopic resection (EFTR), the
ЛЕЧЕНИЕ
38 Онкология и Радиология Казахстана, №4 (70) 2023
volume of lesions subject to endoscopic treatment has significantly expanded even in the colon.
Currently, these methods are regularly used
not only for the treatment of benign tumors but also for complex resection of early stages of colorectal cancer.
For the first time in Kazakhstan,
the presented article analyzed the cases of endoscopic removal of epithelial formations of the large intestine performed at an oncological clinic
from 2020 to 2023.
The aim was to evaluate the use of endoscopic treatment of early colorectal cancer.
Methods: The article presents a retrospective analysis of 68 cases of endoscopic removal of epithelial formations of the colon performed from
2020 to 2023 at the Center of Expert Endoscopy and Interventional Radiology of the National Scientific Cancer Center (Astana, Kazakhstan).
Results: In 2020-2023, 68 endoscopic extractions of colon tumors were performed, including 25 outpatient and 43 inpatient manipulations.
Out of 43 inpatient cases, endoscopic dissection in the submucosal layer was performed in 9 cases, and endoscopic mucosal resection of tumors
of the large intestine was performed in 34 cases.
Morphologically, we found hyperplastic polyps in 11 cases, lipomas in 2 cases, tubulovillous
adenomas with mild dysplasia – 43 cases, tubulovillous adenomas with severe dysplasia – 11 cases, carcinoma in situ – 3 cases, and adenocarcinoma with invasion – 3 cases.
Conclusion: When detecting benign neoplasms with dysplasia and early colorectal cancer, minimally invasive technologies (EMR, ESD,
EFTR) should be the first preferred treatment method and only if they cannot be performed and there is a high risk of invasion into the underlying layers, and therefore, if endoscopic treatment is not radical, clinicians should choose surgical radical treatment.
Patients should
be informed about the availability of the latest methods of local treatment in the Republic through the financing of the Compulsory Medical
Insurance Fund (CMIF).
Related Results
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract
OBJECTIVE:
Colorectal cancer is a cancer with high prevalence and mortality rates worldwide, treated with surger...
The prevention of colorectal cancer
The prevention of colorectal cancer
Colorectal cancer is a leading cause of cancer mortality in the industrialized world. Survival remains poor because most cases are diagnosed at an advanced stage. It is a preventab...
ENDOSCOPIC TREATMENT FOR EARLY COLORECTAL CANCER
ENDOSCOPIC TREATMENT FOR EARLY COLORECTAL CANCER
Relevance: In recent years, significant breakthroughs have occurred in the endoscopic treatment of cancerous and precancerous lesions of the gastrointestinal tract. Endoscopic muco...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract 1557: Overexpressions of ALEX1 gene play a negative role in human colorectal tumorigenesis
Abstract 1557: Overexpressions of ALEX1 gene play a negative role in human colorectal tumorigenesis
Abstract
Background: Arm protein lost in epithelial cancers, on chromosome X (ALEX) is a novel subgroup within the armadillo family which has several ARM repeat doma...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
One-nostril endoscopic endonasal approach for pituitary macroadenoma resection
One-nostril endoscopic endonasal approach for pituitary macroadenoma resection
Abstract
Introduction: Endoscopic techniques have become the standard approach for pituitary adenoma surgery, providing improved visualization of the hypophyseal fossa and facili...

